首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Breast

Breast杂志,由Churchill Livingstone出版,于1992年创刊,Bi-monthly,出版语言English,ISSN:0960-9776,E-ISSN:1532-3080。

投稿咨询
Breast
Breast
Breast
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.2
CiteScore
12.6
期刊收录
SCI、SCIE

Breast(中文译名:《胸部》),ISSN:0960-9776,EISSN:1532-3080,是Churchill Livingstone出版的国际性学术期刊,创刊于1992年,以Bi-monthly形式稳定发行,2026年总发文量约203篇。该刊采用OA开放访问,学科归属为医学 - 妇产科学。该刊是医学、肿瘤学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.2,2025年期刊CiteScore为12.6,2025年期刊自引率约3.8%,在中科院期刊分区体系中位列医学大类2区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Breast长期聚焦医学、肿瘤学及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、肿瘤学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,ItalyUSA、CHINA MAINLAND、Australia、England、France、India等为核心发文国家与地区;UNICANCERIRCCS EUROPEAN INSTITUTE OF ONCOLOGY (IEO)、UNIVERSITY OF MILAN、UNIVERSITY OF SYDNEY、FUNDACAO CHAMPALIMAUD、HARVARD UNIVERSITY、UNIVERSITY OF TORONTO等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
ONCOLOGY 肿瘤学 OBSTETRICS & GYNECOLOGY 妇产科学
2区 1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学
2区 2区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学
2区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY SCIE Q1 9 / 143

94.1

学科:ONCOLOGY SCIE Q1 81 / 333

75.8

学科:OBSTETRICS & GYNECOLOGY SCIE Q1 6 / 143

96.15

学科:ONCOLOGY SCIE Q1 31 / 333

90.84

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:OBSTETRICS & GYNECOLOGY SCIE Q1 4 / 141

97.5

学科:ONCOLOGY SCIE Q1 40 / 328

88

学科:OBSTETRICS & GYNECOLOGY SCIE Q1 9 / 141

93.97

学科:ONCOLOGY SCIE Q1 32 / 328

90.4


中国学者近期发文

1
Recovery quality with regional anesthesia and dexmedetomidine sedation versus general anesthesia for ambulatory breast cancer surgery: A randomized tria

Author:Ling, Dandan; Wei, Shiyou; Wang, Shilai; Wang, Ping; He, Zhiyong; Hu, Zhen; Yu, Sanjian; Wu, Yiqiu; Wang, Bei; Zhang, Jun; Xu, Jianghui

Journal: BREAST. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.breast.2026.104776

2
Locoregional control of downstaged breast-conserving surgery after neoadjuvant chemotherapy: A propensity-matched study in Chinese patient

Author:Zhang, Dongbo; Feng, Qianzhu; Peng, Min; Zhu, Liling; Chen, Kai; Li, Shunrong

Journal: BREAST. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.breast.2026.104775

3
Global patterns and risk factors of breast cancer in women under 35: a population-based stud

Author:Jiao, Dechuang; Zhu, Jiujun; Wang, Dandan; Fei, Junchao; Zhang, Jingyang; Zhang, Jiao; Dai, Hao; Wang, Jia; Zhao, Yajie; Wang, Lina; Gong, Xilong; Xiao, Hui; Guo, Xuhui; Zhang, Chongjian; Wu, Huanmei; Liu, Zhenzhen

Journal: BREAST. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.breast.2026.104777

4
Association between diarrhea and survival in patients with HER2-positive advanced breast cancer treated with pyrotinib-based therapy: A landmark analysis from the real-world PRETTY stud

Author:Li, Yiqun; Wang, Wenna; Tong, Zhongsheng; Wu, Xinhong; Cai, Li; Ouyang, Quchang; Li, Wei; Yu, Zhiyong; Han, Zhengxiang; Wang, Xiaojia; Li, Man; Wang, Haibo; Li, Li; Yang, Jin; Xu, Binghe

Journal: BREAST. 2026; Vol. 87, Issue , pp. -. DOI: 10.1016/j.breast.2026.104783

5
Focusing on toxicity management: Challenges and strategies for HER2-targeted antibody-drug conjugates in breast cance

Author:Liu, Xiaoyu; Yin, Saige; Li, Xiyin; Nie, Jianyun

Journal: BREAST. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.breast.2026.104741

6
Impact of screening on late-stage breast cancer in the Netherlands: a population-based cohort study (2007-2016

Author:Lin, Yixuan; Sidorenkov, Grigory; Wang, Jing; Greuter, Marcel J. W.; Houssami, Nehmat; Dorrius, Monique D.; Siesling, Sabine; de Munck, Linda; de Bock, Geertruida H

Journal: BREAST. 2026; Vol. 86, Issue , pp. -. DOI: 10.1016/j.breast.2026.104745

7
Response to Critical appraisal of a machine learning model for predicting internal mammary lymph node metastasis in breast cance

Author:Xiang, Yirong; Tie, Jian; Wang, Weihu

Journal: BREAST. 2026; Vol. 85, Issue , pp. -. DOI: 10.1016/j.breast.2026.104702

8
Critical appraisal of a machine learning model for predicting internal mammary lymph node metastasis in breast cance

Author:Fang, Kun; Jiang, Suxiao; Zhang, Ping

Journal: BREAST. 2026; Vol. 85, Issue , pp. -. DOI: 10.1016/j.breast.2025.104652

9
Cost-effectiveness of inavolisib plus palbociclib-fulvestrant versus palbociclib plus fulvestrant as first-line treatment in HR+/HER2-advanced breast cance

Author:Zhu, Jiaming; Ding, Ye; Li, Zhengxiong; Liu, Wen

Journal: BREAST. 2026; Vol. 85, Issue , pp. -. DOI: 10.1016/j.breast.2026.104693

10
Multidisciplinary meeting for breast cancer care: EUSOMA recommendations for optimizatio

Author:Curigliano, G.; Marotti, L.; Barrios, C.; Battisti, N. M. L.; Cheung, K. L.; Chia, S.; Graff, S. L.; Hartmann, O. J.; Rubio, I.; Santini, D.; Sardanelli, F.; Senkus, E.; Van Dam, P.; Walker, M.; Wu, J.; Aristei, C

Journal: BREAST. 2026; Vol. 85, Issue , pp. -. DOI: 10.1016/j.breast.2025.104682


在线咨询

Breast

国际简称:BREAST参考译名:胸部

年发文量:203 CiteScore:12.6 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:93.60%

杂志社联系方式:CHURCHILL LIVINGSTONE, JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH, SCOTLAND, MIDLOTHIAN, EH1 3AF

Breast